FTO and hepatocellular carcinoma: FTO overexpression increases the mRNA expression of the glycolysis-associated genes glucose transporter type 1 (GLUT1), pyruvate kinase M2 (PKM2), and c-Myc by decreasing the expression of m6A modifications, which subsequently promotes HCC progression in a glycolysis-dependent manner (52).